Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for Prevention of VRd-Induced Neuropathy in Multiple Myeloma
NCT07025005Phase 4Recruiting
- Sponsor
- Tanta University
- Start
- Aug 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fenofibrate in peripheral neuropathy, sponsored by Tanta University. Started Aug 2025; status: recruiting.
02
Drugs
fenofibrate
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT07025005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07025005.